We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill ((Greenpep))

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified August 2010 by University of Zurich.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01317381
First Posted: March 17, 2011
Last Update Posted: March 17, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Intuitive Surgical
Information provided by:
University of Zurich
  Purpose
ICG- Leberfunktionstest versus "neue" Biomarker als prognostischer Marker bei intensivmedizischen Patienten

Condition Intervention Phase
Critically Ill Patients Procedure: Observational Phase 4

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill

Further study details as provided by University of Zurich:

Estimated Enrollment: 100
Study Start Date: May 2010
Estimated Study Completion Date: May 2011
Groups/Cohorts Assigned Interventions
ICU patients
Admitted patients to the ICU
Procedure: Observational
Blood draw

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Admitted ICU Patients
Criteria

Inclusion criteria: Gruppe 1:

  • Intensiv-Patienten mit Verbrennungen > 10% der Körperoberfläche
  • Alter > 18

Gruppe 2:

  • Intensivpatienten nach grossen chirurgischen Eingriffen
  • Alter > 18

Gruppe 3:

  • Polytraumatisierte, intensivpflichtige Patienten
  • Alter > 18

Exclusion criteria: • Alter < 18

  • Schwangerschaft
  • Einschluss in eine andere Studie
  • Moribunde Patienten
  • Patienten, die kein Deutsch verstehen
  • Jodunverträglichkeit
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01317381


Contacts
Contact: 01 Studienregister MasterAdmins +41 (0)44 255 11 11

Locations
Switzerland
Recruiting
Zurich, Switzerland
Sponsors and Collaborators
University of Zurich
Intuitive Surgical
Investigators
Study Director: 01 Studienregister MasterAdmins UniversitaetsSpital Zuerich
  More Information

Responsible Party: Béchir Markus, PI, CIM
ClinicalTrials.gov Identifier: NCT01317381     History of Changes
Other Study ID Numbers: Version 2.0. 08.12.2
First Submitted: August 23, 2010
First Posted: March 17, 2011
Last Update Posted: March 17, 2011
Last Verified: August 2010

Additional relevant MeSH terms:
Critical Illness
Disease Attributes
Pathologic Processes